• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: STRYKER NEUROVASCULAR CORK TARGET 360 NANO 1.5MM X 2CM; DEVICE, NEUROVASCULAR EMBOLIZATION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

STRYKER NEUROVASCULAR CORK TARGET 360 NANO 1.5MM X 2CM; DEVICE, NEUROVASCULAR EMBOLIZATION Back to Search Results
Catalog Number M0035421520
Medical Device Problem Code Fracture (1260)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 03/16/2025
Type of Reportable Event Malfunction
Event or Problem Description
The subject coil was returned for analysis and the device investigation revealed that the subject coil was broken/fractured during use.There was no clinical consequence to the patient due to this event.
 
Additional Manufacturer Narrative
Due to the automated manufacturing execution system (mes) there are controls in the manufacturing process to ensure the product met specifications upon release.During visual/microscopic inspection, the coil delivery wire was found to be kinked/bent.The main coil was found to be broken/fractured near the detachment zone.During functional testing, the reported coil in catheter friction could not be replicated during device analysis due to damage; however, the analysis results are consistent with the reported event.The reported main coil damage was confirmed.The reported event is covered in the device directions for use (dfu).As well, the risk of the reported event is documented in the risk documentation and there are current controls to mitigate the risk of the as reported event.The reported coil in catheter friction could not be replicated during device analysis due to damage; however, the analysis results are consistent with the reported event.The reported main coil damage was confirmed.The device failed to meet specifications when received for complaint investigation based on the analyzed anomalies noted to the device.It was reported that while advancing the coil into the microcatheter, resistance was encountered, and the coil could not be advanced.The physician then withdrew the coil and found that it had been damaged.Additional information provided by the customer indicated that the device was prepared for use as per the dfu.There was no damage noted to the packaging prior to opening the packaging.The device was confirmed to be in good condition during preparation/ prior to use on the patient.Continuous flush was set up and maintained throughout the clinical procedure.The device was returned for analysis, and it was noted that the coil delivery wire was found to be kinked/bent, and the main coil was found to be broken/fractured near the detachment zone.The reported coil in catheter friction could not be replicated during device analysis due to damage; however, the analysis results are consistent with the reported event.The reported main coil damage was confirmed.An assignable cause of procedural factors will be assigned to the as reported coil in catheter friction and main coil damage as complaint appears to be associated with a product that met stryker design and manufacturing specifications and was used in accordance with the dfu, but performance was limited due to procedural factors during use.An assignable cause of procedural factors will be assigned to as analyzed main coil broken/fractured during use as complaint appears to be associated with a product that met stryker design and manufacturing specifications and was used in accordance with the dfu, but performance was limited due to procedural factors during use.An assignable cause of handling damage will be assigned to as analyzed coil delivery wire kinked/bent since this complaint appears to be associated with handling of the product or portion of the product during the procedure.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TARGET 360 NANO 1.5MM X 2CM
Common Device Name
DEVICE, NEUROVASCULAR EMBOLIZATION
Manufacturer (Section D)
STRYKER NEUROVASCULAR CORK
ida industrial estate
model farm road
cork NA
EI  NA
Manufacturer (Section G)
STRYKER NEUROVASCULAR CORK
ida industrial estate
model farm road
cork NA
EI   NA
Manufacturer Contact
tara lopez
47900 bayside parkway
fremont, CA 94538
5104132500
MDR Report Key22146328
Report Number3008881809-2025-00318
Device Sequence Number20786523
Product Code HCG
UDI-Device Identifier04546540697981
UDI-Public(01)04546540697981(17)290630(10)25016277
Combination Product (Y/N)N
Initial Reporter CountryCH
PMA/510(K) Number
K113412
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source Health Professional
Initial Reporter Occupation Physician
Type of Report Initial
Report Date (Section B) 06/04/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Catalogue NumberM0035421520
Device Lot Number25016277
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer04/04/2025
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 05/13/2025
Initial Report FDA Received Date06/04/2025
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured07/02/2024
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
SL-10 MICROCATHETER (STRYKER).
Patient Age71 YR
Patient SexMale
Patient RaceAsian
-
-